Stocktoria
Lonza Group AG LONN.SW
CH · SIX Swiss Exchange · XSWX · stock · Healthcare · website
Lonza Group AG financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $6.5B | $5.5B | $6.7B | $6.2B |
| Gross profit | $2.3B | $1.8B | $1.9B | $2.4B |
| R&D expense | $112.0M | $102.0M | $105.0M | $95.0M |
| SG&A expense | $765.0M | $712.0M | $837.0M | $827.0M |
| Operating income | $1.4B | $879.0M | $873.0M | $1.4B |
| Interest expense | $163.0M | $140.0M | $93.0M | $63.0M |
| Income tax | $192.0M | $106.0M | $135.0M | $230.0M |
| Net income | -$275.0M | $636.0M | $654.0M | $1.2B |
| EPS (diluted) | — | $8.92 | $8.88 | $16.34 |
| Operating cash flow | $1.2B | $1.3B | $1.4B | $1.0B |
| Free cash flow | -$217.0M | -$143.0M | -$294.0M | -$852.0M |
| Cash & equivalents | $719.0M | $1.1B | $1.5B | $1.3B |
| Inventory | $1.7B | $1.7B | $1.6B | $1.8B |
| Total assets | $17.9B | $19.7B | $16.8B | $17.4B |
| Total liabilities | $9.9B | $10.3B | $7.3B | $6.7B |
| Shareholders' equity | $7.9B | $9.3B | $9.5B | $10.6B |
Growth · year-over-year · Revenue CAGR 1.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +19.2% | -18.4% | +7.9% | — |
| Net income growth | -143.2% | -2.8% | -46.2% | — |
| EPS growth | — | +0.5% | -45.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · CH · as of 2025-12-31. Figures in CHF; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.